EUVIMEDEUVIMED entdecken
Crossref

Cancer risk in gastric hyperplastic polyps: mucosal context rather than polyp features?

Adila Abdulla iD, Chao Li

Endoscopy · 01.05.2026 · 58 (05) · 568

DOI: 10.1055/a-2780-6270 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.05.2026. Verfasst von Adila Abdulla und 1 weiteren Autor:innen. Beteiligte Einrichtung: Gastrointestinal Surgery, The First Hospital of Hebei Medical University, Shijiazhuang, China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Letter to: Malignant progression and recurrence rates following endoscopic treatment of gastric hyperplastic polyps Endoscopy 2025; 57(12): 1348-1354 DOI: 10.1055/a-2631-5146 10.1055/a-2631-5146 We read with great interest the study by Turkot et al. evaluating malignant progression and recurrence after endoscopic treatment of gastric hyperplastic polyps (GHPs) in 889 patients with linkage to the Polish National Cancer Registry [ 1 ]. The authors report neoplasia in 1.2% of resected GHPs (all ≥20 mm, mostly pedunculated) and a substantial local recurrence rate after resection. This registry-linked cohort deserves recognition for its scope and supports a more selective resection strategy for large pedunculated lesions [ 1 ]. As gastric cancer can arise within an atrophic-metaplastic mucosal field that also favors GHP development, attributing registry-detected cancers to malignant progression of a prior GHP may depend on baseline mucosal risk. In the study cohort, assessment of the background mucosa (when available) showed a high prevalence of atrophic gastritis and intestinal metaplasia, and the proposed algorithm appropriately links surveillance to MAPS III recommendations [ 1 ] [ 2 ]. Beyond polyp size and morphology, guidance for patients at risk of gastric adenocarcinoma recommends systematic assessment of premalignant mucosal changes and Helicobacter pylori testing (with eradication when indicated) when planning surveillance [ 2 ] [ 3 ] [ 4 ]. It would therefore be helpful to know: (i) the extent or stage of background atrophy and intestinal metaplasia (and H. pylori status) in the three patients who later developed gastric cancer, and whether cancers occurred at the index polypectomy site or elsewhere in the stomach; and (ii) the cumulative incidence of gastric cancer stratified by background mucosal risk, particularly among patients with 10–19-mm GHPs, in whom cancers were observed [ 1 ]. Such information could help refine how a restrictive resection strategy is integrated with mucosa-based surveillance in routine practice. Publication History Article published online: 22 April 2026 © 2026. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany Letter to this article: Reply to Abdulla and Li Endoscopy 2026; 58(05): 569-569 DOI: 10.1055/a-2831-5307

Autor:innen und Institutionen

  • Gastrointestinal Surgery, The First Hospital of Hebei Medical University, Shijiazhuang, China.

ORCID-Profile: Adila Abdulla

Zitieren

APA

Abdulla, A., & Li, C. (2026). Cancer risk in gastric hyperplastic polyps: mucosal context rather than polyp features?. Endoscopy, 58(05), 568. https://doi.org/10.1055/a-2780-6270

Vancouver

Abdulla A, Li C. Cancer risk in gastric hyperplastic polyps: mucosal context rather than polyp features?. Endoscopy. 2026;58(05):568. doi:10.1055/a-2780-6270

BibTeX
@article{Abdulla2026,
  author = {Abdulla, Adila and Li, Chao},
  title = {Cancer risk in gastric hyperplastic polyps: mucosal context rather than polyp features?},
  journal = {Endoscopy},
  year = {2026},
  volume = {58},
  number = {05},
  pages = {568},
  doi = {10.1055/a-2780-6270}
}
Kostenlos starten →